Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137858) titled 'Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study' on Aug. 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Condition:
Oral Squamous Cell Carcinoma (OSCC)
Neoadjuvant Chemoimmunotherapy
Intervention:
Drug: Preoperative neoadjuvant immunotherapy chemotherapy
Drug: Two courses of p...